14 GHP Q1 2024 Inspired and founded by Professor the Honourable Dr. Henry Lowe’s vision to bring medicinal products and services from Jamaican plants to the local and international markets alike, Medicanja® is a company that leverages the boundless potential of biotechnology to develop naturally made, hemp-based products. Established in 2013, Medicanja® is the beneficiary of its founder’s 50+ years of scientific research into Jamaican plants to create safe, quality products that align with accepted industry standards. Below, we explore the story behind the company, and how its excellence promises a bright new dawn for the industry. Professor Lowe, whose work in cannabis dates back to the 1970s, was able to identify numerous and fascinating benefits from the plant. Inspired by the seemingly endless potential of Jamaica’s ecology, Professor Lowe created Medicanja®, which now acts as a conduit for the brilliance of both himself and his team. The goal is to use biotechnology to develop naturally made, hemp-based products, while upholding an uncontested level of quality in the process. For such pioneering work across his career, Professor Lowe has received numerous awards including the Jamaica Observer Business Leader Award (2006) and the CCRP Living Legend Award (2012). He is also the only Jamaican to have become a member of the prestigious American Association for Cancer Research (AACR), in addition to being a member of the American Association for the Advancement of Science, and a Fellow at the Royal Society of Medicine United Kingdom, Harvard Medical School Postgraduate Association, American Association of Pharmaceutical Scientists, and the American Chemical Society and a Life Member of the New York Academy of Sciences. Whether it’s pursuing the development and commercialisation of a range of pharmaceuticals, nutraceuticals, cosmeceuticals, or functional foods that are designed to treat and manage a range of conditions, the company invests exceptional levels of talent into reaching its desired outcomes. In partnership with collectives, whose cutting-edge research in the medicinal use of cannabis and other such plants has reached impressive heights, Medicanja® has managed to successfully navigate the landscape of the Ministry of Health and Wellness of Jamaica. This allowed the company to gain approval for eleven cannabis-based pharmaceutical products, and a further seven supplements. Though the beginnings of the company started with a focus on the research and development of various products and treatments to which the cannabis plant can be applied, Medicanja® has since spearheaded over 150 innovations at different stages within the pipeline. This exceptional feat in itself stands as a testament to the ingenious minds behind the collective, and it’s clear that the passion doesn’t end there. In fact, due to Medicanja®’s work being so highly regarded by the region’s industry, the company was awarded a Certificate of Recognition from the National Innovation Competition of Jamaica in 2018 – an appreciation that truly identified the immense impact that this brilliant business had created on the overarching industry. However, one of the products that is taking the cannabis-based products hitlist by storm is Medicanja®’s award-winning CBD Oil. Capable of aiding in the relief of mild to moderate symptoms relating to nausea, pain, and inflammation, as well as assisting with reducing the symptoms of those diagnosed with HIV or AIDS, or those suffering the side effects of chemotherapy, this revolutionary product has easily set a new standard. Its all-natural composition – namely Hemp Seed Oil and Vitamin E Oil - not only makes it gentle on a user’s system, but also grants it a therapeutic essence that can be immediately felt following consumption. When considering Medicanja®’s current status within the sector, we believe the company itself puts it best – “Medicanja® is positioned to become the preeminent consumer of cannabis in Jamaica and ball moss, which could become the anchor for growers. After achieving product certification from the MOHW on the first set of products, the company has embarked on a proof-of-concept model to strengthen care provider and consumer response. Medicanja® is also the first company in its industry to receive grant funding for clinical trials in palliative pain management for cancer patients - a project executed jointly with the University of the West Indies Caribbean Institute for Health.” In short, the collective is fully equipped to change the future of the market, and we can only hope that this award will act as further motivation. The future of Medicanja® is exceptionally bright, and we’re certain that it will only continue to flourish as it proceeds with the production of some of its most innovative products to date. Contributing to its ongoing success is a strong local industry, where the company works with local regulators to ensure the processes developed are best practices. It is also working with Jamaica’s export agency, JAMPRO and private sector groups such as Jamaica Manufactures and Exporters Association to ensure it becomes a major exporter of products from Jamaica. This commercial transformation is being led by CEO Dr Trevor Hamilton and COO Andray Mckenzie. Now, the company is seeking other partners to join it on this journey to transform the future of healthcare by providing unique, high-quality products to the world. Contact: Andray Mckenzie Company: Medicanja® Web Address: https://www.medicanja.net/ Best CBD Oil Brand - Jamaica
RkJQdWJsaXNoZXIy MTUyMDQwMA==